Thomas C.  Zielinski net worth and biography

Thomas Zielinski Biography and Net Worth

Thomas C. Zielinski is an a Executive Vice President, General Counsel of Anthem, Inc. Prior to joining us, Mr. Zielinski was a partner in the law firm of Morgan Lewis & Bockius, LLP since 2013. He served as Executive Vice President and General Counsel of Coventry Health Care, Inc. (“Coventry”) (health insurance) from 2007 to 2013 and as Senior Vice President and General Counsel from 2001 to 2007. Prior to joining Coventry, Mr. Zielinski spent 19 years at the law firm of Cozen & O’Connor, P.C.

What is Thomas C. Zielinski's net worth?

The estimated net worth of Thomas C. Zielinski is at least $19.36 million as of April 30th, 2020. Mr. Zielinski owns 48,303 shares of Elevance Health stock worth more than $19,358,635 as of November 15th. This net worth estimate does not reflect any other assets that Mr. Zielinski may own. Learn More about Thomas C. Zielinski's net worth.

How do I contact Thomas C. Zielinski?

The corporate mailing address for Mr. Zielinski and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Thomas C. Zielinski's contact information.

Has Thomas C. Zielinski been buying or selling shares of Elevance Health?

Thomas C. Zielinski has not been actively trading shares of Elevance Health in the last ninety days. Most recently, Thomas C. Zielinski sold 19,306 shares of the business's stock in a transaction on Thursday, April 30th. The shares were sold at an average price of $278.34, for a transaction totalling $5,373,632.04. Following the completion of the sale, the executive vice president now directly owns 48,303 shares of the company's stock, valued at $13,444,657.02. Learn More on Thomas C. Zielinski's trading history.

Who are Elevance Health's active insiders?

Elevance Health's insider roster includes Gail Boudreaux (President, CEO & Director), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Felicia Norwood (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.

Are insiders buying or selling shares of Elevance Health?

In the last year, insiders at the sold shares 6 times. They sold a total of 57,339 shares worth more than $28,701,403.88. The most recent insider tranaction occured on October, 18th when EVP Charles Morgan Kendrick Jr sold 7,417 shares worth more than $3,205,182.38. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.

Information on this page was last updated on 10/18/2024.

Thomas C. Zielinski Insider Trading History at Elevance Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/30/2020Sell19,306$278.34$5,373,632.0448,303View SEC Filing Icon  
12/4/2019Sell10,600$288.33$3,056,298.0035,247View SEC Filing Icon  
6/11/2019Sell8,826$283.92$2,505,877.9233,183View SEC Filing Icon  
11/7/2018Sell7,826$289.71$2,267,270.4629,466View SEC Filing Icon  
3/13/2018Sell20,455$229.23$4,688,899.65View SEC Filing Icon  
8/10/2017Sell9,127$191.25$1,745,538.7526,571View SEC Filing Icon  
3/2/2017Sell22,936$166.29$3,814,027.4417,376View SEC Filing Icon  
8/10/2016Sell5,254$128.83$676,872.8217,935View SEC Filing Icon  
See Full Table

Thomas C. Zielinski Buying and Selling Activity at Elevance Health

This chart shows Thomas C Zielinski's buying and selling at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevance Health Company Overview

Elevance Health logo
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $400.78
Low: $398.43
High: $408.58

50 Day Range

MA: $478.13
Low: $405.83
High: $553.50

2 Week Range

Now: $400.78
Low: $397.98
High: $567.26

Volume

2,616,529 shs

Average Volume

1,164,884 shs

Market Capitalization

$92.95 billion

P/E Ratio

14.61

Dividend Yield

1.59%

Beta

0.85